Recent Finacing
Recent Raise
FluGen develops REDEE FLU, a single-replication live influenza vaccine that infects cells and expresses viral RNA/proteins without producing infectious virus, inducing innate, antibody, and cellular responses in preclinical models.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
